Attached files

file filename
8-K - 8-K - Adeptus Health Inc.adpt-20151022x8k.htm

 

 

C:\Users\mvangb\Desktop\adeptus2.jpg

Exhibit 99.1

 

 

ADPT News - For Immediate Release

 

 

 

 

 

 

 

 

 

 

 

 

 

ADEPTUS HEALTH REPORTS THIRD QUARTER 2015 RESULTS AND RAISES FULL YEAR GUIDANCE

 Systemwide Revenue Increased 89% 

Net Operating Revenue Increased 53% 

Adjusted EBITDA Increased 166% 

 

Lewisville, Texas (October 22, 2015) — Adeptus Health Inc. (NYSE: ADPT) (“ADPT” or the “Company”), the largest operator of freestanding emergency rooms in the U.S., announced its results for the third quarter ended September 30, 2015. All comparisons included in this release are for the same period in the prior year, unless otherwise noted.

 

Third Quarter 2015 Highlights:

 

·

 Systemwide net patient services revenue was $109.0 million versus $57.6 million in prior year, an increase of 89%;

 

·

Net operating revenue was $88.2 million versus $57.6 million in prior year, an increase of 53%;

 

                 Adjusted EBITDA was $18.6 million versus $7.0 million in prior year, an increase of 166%;

 

                 Adjusted earnings per share was $0.31 and GAAP earnings per share was $0.05;

 

                Net income attributable to Adeptus Health Inc. was $0.7 million;

 

                Cash flow provided by operating activities was $4.0 million versus a usage of $14.1 million in prior year; and

 

               The Company opened six freestanding facilities during the third quarter 2015.

 

2015 Guidance

 

Based on our strong performance in the third quarter of 2015 and continued full year growth plans including 24 freestanding facilities and two new hospitals, we are raising our annual guidanceWe expect systemwide net patient services revenue, which includes revenue from our unconsolidated joint ventures, of $405.0 million to $410.0 million for the full year 2015. We expect Adjusted EBITDA of $73.0 million to $75.0 million and Adjusted earnings per share of $1.20 to $1.25 for the full year 2015.

 

Results of Operations for the Third Quarter 2015

 

Thomas S. Hall, Chairman and CEO, stated, “We are pleased with the third quarter results and the progress we are making in executing our strategy. During the quarter, we opened six additional freestanding emergency rooms, announced entry into our fourth state through a new partnership with Ochsner Health System in Louisiana, and prepared to open our second hospital.  As we continued to deliver on our growth plan, we further strengthened our financial position by closing on a  new $175 million senior credit facility, which will both lower our borrowing costs and enhance our flexibility in funding our growth going forward. We are especially proud of the role we, and our partners, are playing in expanding access to the highest quality emergency care in more and more communities. 

 

So far this year, ADPT has opened 22 new facilities, including 12 freestanding emergency facilities in Texas, five freestanding emergency facilities in Colorado, which are part of our partnership with University of Colorado Health and our first hospital, and four freestanding emergency facilities in Arizona with partner, Dignity Health. ADPT will open its second hospital in Dallas-Fort Worth in Q4 2015. Additionally, construction has begun on two hospitals in Colorado and one in Houston, Texas.


 

 

For the third quarter of 2015, ADPT generated total net operating revenue of $88.2 million, an increase of 53%. Net operating revenue excludes revenue from 14 facilities in Colorado,  eight of which were consolidated in the prior year, and the Arizona hospital and its three freestanding facilities, which are accounted for as equity method investments. The increase was primarily attributable to the impact of patient volumes from the expansion of the number of consolidated freestanding facilities from 43 to 57 and annual gross charge increases, offset by the deconsolidation of our Colorado locations due to the UCHealth joint venture.

 

Adjusted EBITDA increased 166% to $18.6 million. This increase was primarily attributable to a $30.6 million increase in net operating revenue and a $4.5 million increase in equity in earnings of unconsolidated joint ventures, partially offset by increases in salaries, wages and benefits and other costs related to our growth initiatives. See "Non-GAAP Financial Measures Description and Reconciliation" and "Reconciliation of Adjusted EBITDA to Net Income (Loss)" below for further information related to Adjusted EBITDA and its reconciliation to net income (loss).

 

ADPT generated net income of $1.5 million for the quarter, of which $0.7 million was attributable to Adeptus Health Inc., compared to a net loss of $3.6 million from the prior year, of which $1.6 million was attributable to Adeptus Health Inc. The increase in net income was due to an increase of $30.6 million in net operating revenue and a $4.5 million increase in equity in earnings of unconsolidated joint ventures.  This increase was partially offset by increases in salaries, wages and benefits and other costs related to our growth initiatives and an increase in depreciation and amortization expense.

 

Adjusted earnings per share was $0.31 per share and GAAP earnings per share was $0.05 per share for the quarter. Adjusted earnings per share is calculated using a weighted average of both Class A and Class B common shares outstanding, which was an aggregate of 20,767,707 common shares at September 30, 2015. Adjustments for the quarter include $5.1 million of preopening costs associated with new facility openings, $0.8 million of stock compensation expense, $1.1 million related to public offerings of our Class A common stock and $0.7 million of other costs associated with our growth initiatives and an adjustment for taxes in order to establish a normalized tax rate of 35% for comparability purposes. See "Non-GAAP Financial Measures Description and Reconciliation" and "Earnings Per Share Reconciliation" below for further information related to Adjusted earnings per share and its reconciliation to net income (loss).

 

Systemwide Financial Results

 

For the third quarter of 2015, ADPT generated systemwide net patient services revenue of $109.0 million, an increase of 89%.  The increase was primarily attributable to the impact of increased patient volumes from the expansion of the number of freestanding facilities from 51 to 74, annual gross charge increases and the opening of the Dignity Health Arizona General Hospital, a full service general hospital located in Laveen, Arizona.

 

As of September 30, 2015,  14 freestanding facilities associated with our joint venture with University of Colorado Health and our Arizona hospital and its three freestanding facilities associated with our joint venture with Dignity Health were accounted for using the equity method. For consolidated subsidiaries, the Company’s financial statements reflect 100% of the revenues and expenses for these subsidiaries, after elimination of intercompany transactions and accounts. For our unconsolidated joint ventures, consolidated statements of operations reflect those earnings in two line items:

 

·

Equity in earnings of unconsolidated joint ventures, which represents our share of the net income or loss of each equity method joint venture based on our ownership percentage; and

·

Management and contract services revenues, which represent the Company’s combined income from management and contract services that are earned from managing the day-to-day operations and providing contract staffing of the facility.

 

As a result of this accounting treatment in our reported results, management supplementally focuses on non-GAAP systemwide metrics to analyze the results of operations. These systemwide metrics include systemwide net patient services revenue. Systemwide metrics treat our unconsolidated facilities as if they were consolidated. While the revenues earned at the unconsolidated facilities are not recorded in our consolidated financial statements, management believes systemwide net patient services revenue growth is important to understand the Company’s financial performance because it is used to interpret the sources of our growth and provide a growth metric incorporating the revenues earned by all affiliated facilities, regardless of the accounting treatment. As we execute on our strategy of partnering with health systems, management expects the number of our facilities accounted for under the equity method to increase relative to the total number of affiliated facilities.

 

Liquidity

 

At the end of the third quarter, the Company had cash of $46.3 million and $9.5 million available under its revolving credit facility.  Net cash flow from operations was $4.0 million for the third quarter.  At September 30, 2015, the Company had total long-term debt and capital lease obligations of $158.7 million and debt net of cash of $112.4 million.

 


 

In October 2015, the Company closed on a  new $175.0 million senior credit facility.  The new senior credit facility includes a $50.0 million revolver and a $125.0 million term loan. As a result of this new facility our interest rate has been reduced to LIBOR plus 3.75% from LIBOR plus 7.5%. The proceeds from the new credit facility along with a portion of existing cash were used to pay off the previous credit facility.

 

Market Outlook

 

We are maintaining the growth of our freestanding emergency room network at an expected rate of opening 24 new sites per year, including both owned and joint venture facilities. Our second hospital, located in Carrollton, Texas, a Dallas-Ft Worth suburb, remains on schedule to open in the fourth quarter. 

 

ADPT’s growth is addressing the shortage of quality emergency medical care in the U.S. As the most recent American College of Emergency Physicians (ACEP) survey highlights, America's emergency care system remains overstretched as emergency visits continue to rise. Respondents noted that this rise is combined in part with an increase in the acuity of patients’ injuries and/or illnesses. Again, this underscores the growing need for additional access points to high quality, 24/7 emergency care. Our facilities offer just that with convenient neighborhood locations.

 

By creating new independent facilities located within neighborhoods and partnering with leading local healthcare systems, such as Dignity Health, UCHealth, and Ochsner Health System, we are part of the solution that is transforming the delivery of emergency medical care in the U.S.,” added Hall.

 

Conference Call

 

A live audio webcast to present the third quarter results will take place today at 11:00 am (Eastern Time), hosted by Thomas S. Hall, Chairman and CEO, Timothy Fielding, CFO,  and Graham Cherrington, President and COO.

 

The audio webcast will be available by accessing:  [https://www.webcaster4.com/Webcast/Page/1069/10992] 

 

Following the call, an archived recording of the replay will also be available on the Adeptus Health Investor Relations page for 30 days:  http://ir.adeptushealth.com/events-and-presentations/events/default.aspx

 

 

 

About Adeptus Health Inc.

 

Adeptus Health (NYSE:ADPT) is a leading patient-centered healthcare organization expanding access to the highest quality emergency medical care through its network of freestanding emergency rooms and partnerships with premier healthcare providers.  In Texas, Adeptus Health owns and operates First Choice Emergency Room, the nation's largest and oldest network of independent freestanding emergency rooms. In Colorado, in partnership with University of Colorado Health, Adeptus Health operates UCHealth Emergency Rooms. In Arizona, with Dignity Health, the company operates Dignity Health Arizona General Hospital and freestanding emergency rooms. In Louisiana, Adeptus Health has a partnership with Ochsner Health System, the state’s largest healthcare system, to improve access to emergency medical care. All Adeptus Health freestanding facilities are fully equipped emergency rooms with a complete radiology suite of diagnostic technology (CT scanner, ultrasound, and digital X-ray), on-site laboratory, and staffed with board-certified physicians and emergency trained registered nurses. According to patient feedback collected by Press Ganey Associates Inc., Adeptus Health provides the highest quality emergency medical care and received the 2013 and 2014 Press Ganey Guardian of Excellence Award for exceeding the 95th percentile in patient satisfaction nationwide. For more information please visit us on the web at adhc.com.

 

 

 

 

 

 

 

 

 

Media Contact:

Jackie Zupsic

Hill & Knowlton Strategies

Jackie.Zupsic@hkstrategies.com 

Tel: (212) 885 – 0590 

 

 

Investor Relations Contact:

Susan A. Noonan

S.A. Noonan Communications

susan@sanoonan.com 

Tel: (212) 966 – 3650 

 

 

 


 

Forward-Looking Statements

 

Certain statements and information herein may be deemed to be “forward-looking statements” within the meaning of the Federal Private Securities Litigation Reform Act of 1995. Forward-looking statements may include, but are not limited to, statements relating to our guidance, objectives, plans and strategies, and all statements (other than statements of historical facts) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. Any forward-looking statements herein are made as of the date of this press release, and ADPT undertakes no duty to update or revise any such statements except as required by the federal securities laws. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in ADPT’s filings with the U.S. Securities and Exchange Commission (“SEC”) from time to time and which are accessible on the SEC’s website at www.sec.gov, including in the section entitled “Risk Factors” in the Company’s Form 10-K for the fiscal year ended December 31, 2014. Among the factors that could cause future results to differ materially from those provided in this press release are: our ability to implement our growth strategy; our ability to maintain sufficient levels of cash flow to meet growth expectations; our ability to protect our brand; federal and state laws and regulations relating to our facilities, which could lead to the incurrence of significant penalties by us or require us to make significant changes to our operations; our ability to locate available facility sites on terms acceptable to us; competition from hospitals, clinics and other emergency care providers; our dependence on payments from third-party payors; our ability to source and procure new products and equipment to meet patient preferences; our reliance on Medical Properties Trust (“MPT”) and the MPT Master Funding and Development Agreements; disruptions in the global financial markets leading to difficulty in borrowing sufficient amounts of capital to finance the carrying costs of inventory to pay for capital expenditures and operating costs; our ability or the ability of our healthcare system partners to negotiate favorable contracts or renew existing contracts with third-party payors on favorable terms; significant changes in our payor mix or case mix resulting from fluctuations in the types of cases treated at our facilities; significant changes in the rules, regulations and systems governing Medicare and Medicaid reimbursements; material changes in IRS revenue rulings, case law or the interpretation of such rulings; shortages of, or quality control issues with, emergency care-related products, equipment and medical supplies that could result in a disruption of our operations; the intense competition we face for patients, physician use of our facilities, strategic relationships and commercial payor contracts; the fact that we are subject to significant malpractice and related legal claims; the growth of patient receivables or the deterioration in the ability to collect on those accounts; the impact on us of PPACA, which represents a significant change to the healthcare industry; and ensuring our continued compliance with HIPAA, which could require us to expend significant resources and capital; and the factors discussed in the section entitled “Risk Factors” in the Company’s Form 10-K for the fiscal year ended December 31, 2014.

 

Non-GAAP Financial Measures Description and Reconciliation

 

This press release includes presentations of Adjusted EBITDA, which is defined as net income before interest, taxes, depreciation and amortization, further adjusted to eliminate the impact of certain additional items, including, advisory services paid to our Sponsor, facility pre-opening expenses, management recruiting expenses, stock compensation expense and other non-recurring costs or gains.

 

This press release also includes presentation of Adjusted earnings (loss) per share, which is defined as earnings (loss) per share related to the Company’s overall operation, including controlling and non-controlling interests, as adjusted to exclude certain additional items, including, advisory services paid to our Sponsor, facility preopening expenses, management recruiting expenses, stock compensation expense and other non-recurring costs or gains and an adjustment for taxes in order to establish a normalized tax rate of 35% for comparability purposes, divided by the aggregate number of shares of Class A and Class B common stock outstanding as of the end of the period.

 

In addition, this press release presents systemwide metrics to analyze the results of operations. These systemwide metrics include systemwide net patient services revenue.  Systemwide metrics treat our unconsolidated facilities as if they were consolidated.

 

These non-GAAP financial measures, Adjusted EBITDA, Adjusted earnings (loss) per share and systemwide metrics, are commonly used by management and investors as performance measures. The Company’s non-GAAP financial measures are not considered measures of financial performance under U.S. generally accepted accounting principles (GAAP), and the items excluded therefrom are significant components in understanding and assessing our financial performance. These non-GAAP financial measures should not be considered in isolation or as an alternative to GAAP measures such as net income, cash flows provided by or used in operating, investing or financing activities or other financial statement data presented in our consolidated financial statements as an indicator of financial performance. Reconciliations of non-GAAP financial measures are provided in this press release.  Since these non-GAAP financial measures are not measures determined in accordance with GAAP and are susceptible to varying calculations, these measures, as presented, may not be comparable to other similarly titled measures of other companies.

 

 


 

 

Adeptus Health Inc.

Condensed Consolidated Statements of Operations and Other Information

(unaudited; in thousands, except shares, per share data and other information)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended 

 

Nine months ended

 

September 30,

 

September 30,

 

2015

 

2014

 

2015

2014

 

 

 

 

 

 

 

Patient service revenue

$
101,254

 

$
66,533

 

$
301,519
$
163,008

Provision for bad debt

(17,907)

 

(8,934)

 

(50,365)
(22,390)

Net patient service revenue

83,347

 

57,599

 

251,154
140,618

Management and contract services revenue

4,865

 

 -

 

8,098

 -

Total net operating revenue

88,212

 

57,599

 

259,252
140,618

Equity in earnings of unconsolidated joint ventures

4,543

 

 -

 

7,470

 -

Operating expenses:

 

 

 

 

 

 

Salaries, wages and benefits

55,420

 

38,119

 

155,424
92,577

General and administrative

13,866

 

9,221

 

35,701
26,744

Other operating expenses

13,152

 

7,414

 

36,998
17,416

Depreciation and amortization

4,259

 

3,924

 

13,538
10,374

Total operating expenses

86,697

 

58,678

 

241,661
147,111

Income (loss) from operations

6,058

 

(1,079)

 

25,061
(6,493)

Other income (expense):

 

 

 

 

 

 

Gain on contribution to joint venture

 -

 

 -

 

24,250

 -

Interest expense

(3,753)

 

(2,635)

 

(10,925)
(9,160)

Total other (expense) income

(3,753)

 

(2,635)

 

13,325
(9,160)

Income (loss) before provision for income taxes

2,305

 

(3,714)

 

38,386
(15,653)

Provision (benefit) for income taxes

811

 

(116)

 

7,617
142

Net income (loss)

1,494

 

(3,598)

 

30,769
(15,795)

Less: Net income (loss) attributable to the non-controlling interest

820

 

(2,001)

 

18,867
(12,182)

Net income (loss) attributable to Adeptus Health Inc. 

$
674

 

$
(1,597)

 

$
11,902
$
(3,613)

Net income (loss) per share of Class A common stock:

 

 

 

 

 

 

Basic

$
0.05

 

$
(0.16)

 

$
1.05
$
(0.37)

Diluted

$
0.05

 

$
(0.16)

 

$
1.05
$
(0.37)

Weighted average shares of Class A common stock:

 

 

 

 

 

 

Basic

13,236,064

 

9,845,016

 

11,377,557
9,845,016

Diluted

13,236,064

 

9,845,016

 

11,377,557
9,845,016

 

 

 

 

 

 

 

Other information

 

 

 

 

 

 

Number of systemwide facilities, including one hospital

75

 

51

 

75
51

 


 

Adeptus Health Inc.

Reconciliation of Adjusted EBITDA to Net Income (Loss) 

(unaudited; in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended 

 

Nine months ended

 

 

September 30,

 

September 30,

 

 

2015

2014

 

2015

2014

 

 

 

 

 

 

 

 

Net income (loss)

$
1,494
$
(3,598)

 

$
30,769
$
(15,795)

 

Depreciation and amortization

4,902
3,924

 

14,587
10,374

 

Interest expense

3,753
2,635

 

10,925
9,160

 

Provision (benefit) for income taxes

811
(116)

 

7,617
142

 

Gain on contribution to joint venture

 -

 -

 

(24,250)

 -

 

Advisory services arrangement fees and expenses

 -

 -

 

 -

293

 

Preopening expenses

5,102
3,098

 

9,191
6,107

 

Management recruiting expenses

 -

 -

 

185
156

 

Stock compensation expense

789
357

 

1,946
696

 

Public offering expenses

1,079
159

 

2,072
5,157

 

Other

711
541

 

1,801
1,747

 

Total adjustments

17,147
10,598

 

24,074
33,832

 

Adjusted EBITDA

$
18,641
$
7,000

 

$
54,843
$
18,037

 

 

 

 

Adjusted Earnings Per Share Reconciliation

 (unaudited; in thousands, except shares, per share data and other information)

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended 

 

Nine months ended

 

 

September 30,

 

September 30,

 

 

2015

2014

 

2015

2014

 

Weighted average common shares outstanding

 

 

 

 

 

 

       Class A common shares

13,236,064
9,845,016

 

12,351,735
9,845,016

 

       Class B common shares

7,531,643
10,781,153

 

8,388,962
10,781,153

 

Total Class A and B common shares

20,767,707
20,626,169

 

20,740,697
20,626,169

 

 

 

 

 

 

 

 

Net income (loss) attributable to Adeptus Health Inc.

$
674
$
(1,597)

 

$
11,902
$
(3,613)

 

Net income (loss) attributable to non-controlling interest

820
(2,001)

 

18,867
(12,182)

 

Total net income (loss)

1,494
(3,598)

 

30,769
(15,795)

 

 

 

 

 

 

 

 

Adjustments:

 

 

 

 

 

 

 Gain on contribution to joint venture

 -

 -

 

(24,250)

 -

 

 Preopening expenses

5,102
3,098

 

9,191
6,107

 

 Stock compensation expense

789
357

 

1,946
696

 

 Public offering costs

1,079
159

 

2,072
5,157

 

 Other

711
541

 

1,986
2,196

 

 Total adjustments

7,681
4,155

 

(9,055)
14,156

 

 Tax impact of adjustments (1)

(2,688)
(1,454)

 

3,169
(4,955)

 

 Tax adjustment resulting from applying effective tax rate (2)

4
1,184

 

(5,818)
5,621

 

Adjusted net income (loss)

6,491
287

 

19,065
(973)

 

Adjusted net income (loss) per share

$
0.31
$
0.01

 

$
0.92
$
(0.05)

 

 

 

 

 

 

 

 

 

 

 

(1) Reflects the removal of the tax benefit associated with the adjustments

 

 

(2) Represents adjusting to a normalized effective tax rate of 35%

 

 


 

 

Systemwide Net Patient Services Revenue

(unaudited; in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended 

 

Nine months ended

 

 

September 30,

 

September 30,

 

    

2015

 

2014

 

2015

 

2014

Net Patient Services Revenue:

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated facilities

 

$

83,347

 

$

57,599

 

$

251,154

 

$

140,618

Unconsolidated joint ventures

 

 

25,691

 

 

 —

 

 

46,354

 

 

 —

Systemwide net patient services revenue

 

$

109,038

 

$

57,599

 

$

297,508

 

$

140,618

 

 


 

Adeptus Health Inc.

Condensed Consolidated Balance Sheets

(in thousands)

 

 

 

 

 

 

September 30,

 

December 31,

 

2015

 

2014

ASSETS

(unaudited)

 

(audited)

Current assets

 

 

 

Cash

$
46,310

 

$
2,002

Restricted cash

9,166

 

4,795

Accounts receivable, less allowance for doubtful accounts of $30,842 and $13,068, respectively

48,809

 

37,422

Other receivables and current assets

24,840

 

17,137

Medical supplies inventory

4,299

 

4,287

Total current assets

133,424

 

65,643

Property and equipment, net

72,357

 

93,892

Investment in unconsolidated joint ventures

43,847

 

2,100

Deposits

786

 

1,772

Deferred tax asset

203,257

 

34,084

Intangibles, net

18,680

 

20,015

Goodwill

61,009

 

61,009

Other long term assets

5,730

 

4,303

Total assets

$
539,090

 

$
282,818

 

 

 

 

LIABILITIES AND SHAREHOLDERS' EQUITY

 

 

 

Current liabilities

 

 

 

Accounts payable and accrued expenses

$
21,900

 

$
25,420

Accrued compensation

20,069

 

13,521

Current maturities of long-term debt

4,448

 

1,816

Current maturities of capital lease obligations

96

 

81

Deferred rent

814

 

607

Total current liabilities

47,327

 

41,445

Long-term debt, less current maturities

150,204

 

104,982

Payable to related parties pursuant to tax receivable agreement

187,584

 

30,039

Capital lease obligation, less current maturities

3,981

 

4,056

Deferred rent

3,207

 

2,416

Total liabilities

392,303

 

182,938

Commitments and contingencies

 

 

 

Shareholders' equity

 

 

 

Preferred stock, par value $0.01 per share; 10,000,000 shares authorized and zero shares issued and outstanding at September 30, 2015

 -

 

 -

Class A common stock, par value $0.01 per share; 50,000,000 shares authorized, 14,257,599 and 9,845,016 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively

143

 

98

Class B common stock, par value $0.01 per share; 20,000,000 shares authorized, 6,510,108 and 10,781,153 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively

65

 

108

Additional paid in capital

84,706

 

51,238

Accumulated other comprehensive loss

(92)

 

(74)

Retained earnings (deficit)

5,008

 

(3,351)

Non-controlling interest

56,957

 

51,861

Total shareholders' equity

146,787

 

99,880

Total liabilities and shareholders' equity

$
539,090

 

$
282,818

 


 

Adeptus Health Inc.

Condensed Consolidated Statements of Cash Flows

(unaudited; in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended 

 

Nine months ended

 

 

 

September 30,

 

September 30,

 

 

 

2015

2014

 

2015

2014

 

Cash flows from operating activities:

 

 

 

 

 

 

 

Net income (loss)

 

$
1,494
$
(3,598)

 

$
30,769
$
(15,795)

 

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

 

 

 

 

 

 

 

    Loss from the disposal or impairment of assets

 

 -

1

 

68
3

 

    Depreciation and amortization

 

4,259
3,924

 

13,538
10,374

 

    Deferred tax benefit

 

1,951
(1,033)

 

6,328
(1,033)

 

    Amortization of deferred loan costs

 

251
219

 

719
672

 

    Provision for bad debts

 

17,907
8,934

 

50,366
22,390

 

    Gain on contribution to unconsolidated joint ventures

 

 -

 -

 

(24,250)

 -

 

    Equity in earnings of unconsolidated joint ventures

 

(4,543)

 -

 

(7,470)

 -

 

    Stock-based compensation

 

789
359

 

1,946
696

 

    Changes in operating assets and liabilities

 

 

 

 

 

 

 

       Restricted cash

 

(1,362)
(597)

 

(4,371)
(4,498)

 

       Accounts receivable

 

(20,378)
(15,117)

 

(61,753)
(35,560)

 

       Other receivables and current assets

 

(3,412)
(3,872)

 

(4,363)
(2,538)

 

       Medical supplies inventory

 

(692)
(976)

 

(852)
(1,982)

 

       Other long-term assets

 

(481)
17

 

(591)
45

 

       Accounts payable and accrued expenses

 

924
(3,275)

 

(3,215)
585

 

       Accrued compensation

 

7,012
174

 

6,548
3,994

 

       Deferred rent

 

326
708

 

1,703
1,804

 

   Net cash provided by (used in) operating activities

 

4,045
(14,132)

 

5,120
(20,843)

 

Cash flows from investing activities:

 

 

 

 

 

 

 

Deposits

 

(64)
(231)

 

921
(470)

 

Proceeds from the sale of property and equipment

 

 -

 -

 

1,527
2,003

 

Capital expenditures

 

(1,646)
(14,810)

 

(4,916)
(36,830)

 

         Net cash used in investing activities

 

(1,710)
(15,041)

 

(2,468)
(35,297)

 

Cash flows from financing activities:

 

 

 

 

 

 

 

Proceeds from public offerings, net of underwriters fees and expenses

 

265,950

 -

 

360,420
96,226

 

Purchase of limited liability units from LLC Unit holders

 

(265,950)

 -

 

(360,420)

 -

 

Proceeds from long-term borrowings

 

 -

 -

 

54,000
93,955

 

Payment of deferred loan costs

 

(1,078)
(111)

 

(1,573)
(702)

 

Payments on borrowings

 

(273)
(265)

 

(6,964)
(69,642)

 

Payments of capital lease obligations

 

(21)
(16)

 

(60)
(39)

 

Payment of dividends

 

 -

 -

 

 -

(60,000)

 

Forfeiture of restricted stock on vesting

 

(205)

 -

 

(205)

 -

 

Tax distribution to unit holders

 

(577)

 -

 

(3,542)
(9)

 

Contribution from original owner

 

 -

 -

 

 -

167

 

         Net cash provided by (used) financing activities

 

(2,154)
(392)

 

41,656
59,956

 

Net increase (decrease) in cash and cash equivalents

 

181
(29,565)

 

44,308
3,816

 

Cash, beginning of period

 

46,129
44,876

 

2,002
11,495

 

Cash, end of period

 

$
46,310
$
15,311

 

$
46,310
$
15,311